Delivery Order SPE2DB20D7061-SPE2DB26FSLC9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 5, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $4,088.04. The award is structured as a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 3, 2025, for the supply of Trulicity 3 mg/0.5 mL pen auto-injectors valued at $4,607.37. This competitively awarded delivery order employs firm fixed price pricing and is scheduled for completion by November 4, 2025. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injections. The contract, valued at $4,379.01, represents a firm fixed price delivery order with an ultimate completion date of November 3, 2025. The place of performance is identified as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This award was competitively awarded without set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,878.61 by the Defense Logistics Agency (DLA) on September 18, 2025, with a completion date of September 19, 2025. The contract covers the supply of Trulicity 1.5 mg/0.5 mL pen injectable medication, a diabetes treatment. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on September 12, 2025. The contract is valued at $1,201.20 under firm fixed-price terms with an ultimate completion date of September 15, 2025. This delivery order is not set-aside and represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a contract value of $2,303.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set to be completed by October 31, 2025, with the place of performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,006.00 by the Defense Logistics Agency on August 5, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. The contract, designated as firm fixed price with no set-aside provisions, represents a competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,336.40 by the Defense Logistics Agency on October 24, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is not set-aside and represents a competitive award to support federal medical procurement needs. The contract utilizes a non-competitive delivery order structure, with a completion date of October 27, 2025, and will be...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB26FSLC9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 31, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injectors. The contract, valued at $9,009, represents a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and was awarded through open competition with no set-aside designation. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. Trulicity, a diabetes management medication, falls within the company's extensive portfolio of therapeutic products delivered under this vehicle to federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 10/31/25 |